The role of a new formulation of fenofibric acid in the treatment of mixed dyslipidemia in type 2 diabetes

dc.contributor.authorCampbell, J.en_US
dc.contributor.authorMohiuddin, S. M.en_US
dc.contributor.cuauthorCampbell, Jennifer A.en_US
dc.contributor.cuauthorMohiuddin, Syed M.en_US
dc.date.accessioned2014-06-27T13:32:05Z
dc.date.available2014-06-27T13:32:05Z
dc.date.issued2010en_US
dc.date.monthOctoberen_US
dc.date.year2010en_US
dc.description.issue10en_US
dc.description.pages757-764en_US
dc.description.volume46en_US
dc.identifier.citationCampbell, J. and Mohiuddin, S. M. The role of a new formulation of fenofibric acid in the treatment of mixed dyslipidemia in type 2 diabetes. Drugs of today. 2010, Oct. 46(10):757-764.en_US
dc.identifier.pmid21076712en_US
dc.identifier.urihttp://hdl.handle.net/10504/56042
dc.program.unitSchool of Medicineen_US
dc.program.unitDepartment of Medicineen_US
dc.program.unitCardiologyen_US
dc.titleThe role of a new formulation of fenofibric acid in the treatment of mixed dyslipidemia in type 2 diabetesen_US
dc.title.workDrugs of Todayen_US
dc.typeJournal Articleen_US
dc.url.link1http://dx.doi.org/10.1358/dot.2010.46.10.1519652en_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: